Which chapter encompasses guidelines to prevent harm from excessive bacterial endotoxins?

The guidelines to prevent harm from excessive bacterial endotoxins are found in Chapter 797. This chapter specifically addresses the requirements for sterile compounding, emphasizing the need for practices that minimize the risk of contamination and ensure the safety and efficacy of compounded sterile preparations.

Bacterial endotoxins, which are harmful byproducts from bacterial cell walls, can pose significant health risks if present in sterile products. Chapter 797 outlines rigorous standards including personnel training, environmental controls, and facility design aimed at reducing the risk of contamination, thereby ensuring patient safety. The chapter emphasizes proper aseptic techniques and the validation of processes to control endotoxin levels, making it essential for sterile compounding practices.

The other chapters focus on different aspects of compounding and do not specifically address the prevention of harm from bacterial endotoxins. For instance, Chapter 795 covers non-sterile compounding, while Chapter 800 deals with handling hazardous drugs, and Chapter 900 pertains to compounding quality standards more generally but does not specifically delve into endotoxin control.